This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
BACKGROUND:Diabetes may be associated with differential outcomes in patients undergoing left main coronary revascularization with percutaneous coronary intervention (PCI) or coronaryarterybypassgrafting (CABG). Patients were categorized by diabetes status. PintHR=0.87) diabetes.
Left main coronaryartery disease (CAD) and diabetes pose significant challenges in cardiovascular care, often leading to adverse outcomes. However, the comparative long-term efficacy of percutaneous coronary intervention (PCI) versus coronaryarterybypassgrafting (CABG) in patients with these conditions remains unclear.
Eagle looks at the difference between quantitative coronary angiography versus intervascular ultrasound to guide PCI. He then discusses paclitaxel-coated balloon catheters vs uncoated balloon angioplasty for treating coronary in-stent restenosis.
In many trials, revascularisation in addition to OMT was not effective in either improving survival or reducing adverse events compared with OMT alone, except for a subcohort of patients treated with coronaryarterybypassgrafting (CABG) in BARI-2D (BypassAngioplasty Revascularization Investigation 2 Diabetes) trial.
As age advances and depending on risk factors like heredity, smoking, high blood pressure and diabetes, fat build up occurs in these blood vessels. Bypass surgery certainly provides much better long term results than balloon angioplasty and stent insertion. But the initial worries about an open surgery is definitely there.
Conditions like preeclampsia, gestational diabetes, and hypertension during pregnancy are not only dangerous during pregnancy but also serve as indicators of future cardiovascular problems. Women who experience these complications should be vigilant about their heart health later in life.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
81 
Let's personalize your content